FDA and CDC Lift Recommended Pause on Johnson & Johnson …
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease...
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 …
Apr 13, 2021 · As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases...
Janssen COVID-19 Vaccine | FDA - U.S. Food and Drug Administration
Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
J&J’s COVID vaccine is dead in the US; FDA revokes authorization
Jun 6, 2023 · The Food and Drug Administration has withdrawn authorization for Johnson & Johnson's COVID-19 vaccine, ending its short-lived but troubled existence amid the pandemic.
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA …
The Janssen COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older.
SPRAVATO - Johnson & Johnson
Jan 21, 2025 · Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO ® (esketamine) CIII nasal spray, making this innovative treatment the first and only monotherapy for adults living with major depressive disorder (MDD) who have had an inadequate response to ...
FDA puts strict limits on Johnson & Johnson Covid-19 vaccine
May 5, 2022 · The US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom...
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized …
Oct 20, 2021 · NEW BRUNSWICK, N.J., October 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single ...
FDA approves Johnson & Johnson nasal spray Spravato for …
Jan 21, 2025 · Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
Statement from NIH and BARDA on the FDA Emergency Use …
Feb 27, 2021 · Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.
- Some results have been removed